Chemical chaperone 4-phenylbutyrate prevents endoplasmic reticulum stress induced by T17M rhodopsin

Cell & Bioscience

Xiaobo Xia¹  Siqi Xiong¹  Haibo Jiang¹ 

[1] Department of Ophthalmology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410078, P.R. China

关键词: ERAD;    Misfolded;    UPR;    Rhodopsin;    Retinitis pigmentosa;   

Others  :  1135311
DOI  :  10.1186/2045-3701-4-75

 received in 2014-09-05, accepted in 2014-11-25,  发布年份 2014

【 摘 要 】

Background

Rhodopsin mutations are associated with the autosomal dominant form of retinitis pigmentosa. T17M mutation in rhodopsin predisposes cells to endoplasmic reticulum (ER) stress and induces cell death. This study aimed to examine whether chemical chaperone 4-phenylbutyrate prevents ER stress induced by rhodopsin T17M.

Results

ARPE-19 cells were transfected with myc-tagged wild-type (WT) and T17M rhodopsin constructs. Turnover of WT and T17M rhodopsin was measured by cycloheximide chase analysis. The activity of ubiquitin-proteasome system was evaluated by GFPU reporter. We found that T17M rhodopsin was misfolded, ubiqutinated and eliminated by ER-associated degradation pathway (ERAD) in ARPE-19 cells. Accumulated T17M rhodopsin induced unfolded protein response, but had no effect on the activity of ubiquitin proteasome system. Moreover, chemical chaperone 4-phenylbutyrate facilitated the turnover of T17M rhodopsin and prevented apoptosis and ER stress induced by T17M rhodopsin.

Conclusions

Chemical chaperone could attenuate UPR signaling and ER stress induced by T17M rhodopsin and has potential therapeutic significance for retinitis pigmentosa.

【 授权许可】

   
2014 Jiang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Rosenberg T: Epidemiology of hereditary ocular disorders. Dev Ophthalmol 2003, 37:16-33.
• [2]Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, Sandberg MA, Berson EL: Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med 1990, 323:1302-1307.
• [3]Hartong DT, Berson EL, Dryja TP: Retinitis pigmentosa. Lancet 2006, 368:1795-1809.
• [4]Rivolta C, Sharon D, DeAngelis MM, Dryja TP: Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet 2002, 11:1219-1227.
• [5]Berson EL: Retinitis pigmentosa: unfolding its mystery. Proc Natl Acad Sci U S A 1996, 93:4526-4528.
• [6]Li T, Sandberg MA, Pawlyk BS, Rosner B, Hayes KC, Dryja TP, Berson EL: Effect of vitamin A supplementation on rhodopsin mutants threonine-17 methionine and proline-347 serine in transgenic mice and in cell cultures. Proc Natl Acad Sci U S A 1998, 95:11933-11938.
• [7]Kaushal S, Khorana HG: Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994, 33:6121-6128.
• [8]White DA, Fritz JJ, Hauswirth WW, Kaushal S, Lewin AS: Increased sensitivity to light-induced damage in a mouse model of autosomal dominant retinal disease. Invest Ophthalmol Vis Sci 2007, 48:1942-1951.
• [9]Kunte MM, Choudhury S, Manheim JF, Shinde VM, Miura M, Chiodo VA, Hauswirth WW, Gorbatyuk OS, Gorbatyuk MS: ER stress is involved in T17M rhodopsin-induced retinal degeneration. Invest Ophthalmol Vis Sci 2012, 53:3792-3800.
• [10]Jiang H, Xiong S, Xia X: Retinitis pigmentosaassociated rhodopsin mutant T17M induces endoplasmic reticulum (ER) stress and sensitizes cells to ER stress-induced cell death. Mol Med Rep 2014, 9:1737-1742.
• [11]Romisch K: Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol 2005, 21:435-456.
• [12]Zhong X, Shen Y, Ballar P, Apostolou A, Agami R, Fang S: AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J Biol Chem 2004, 279:45676-45684.
• [13]Gilon T, Chomsky O, Kulka RG: Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae. EMBO J 1998, 17:2759-2766.
• [14]Hampton RY: ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 2002, 14:476-482.
• [15]Liang J, Yin C, Doong H, Fang S, Peterhoff C, Nixon RA, Monteiro MJ: Characterization of erasin (UBXD2): a new ER protein that promotes ER-associated protein degradation. J Cell Sci 2006, 119:4011-4024.
• [16]DeLaBarre B, Christianson JC, Kopito RR, Brunger AT: Central pore residues mediate the p97/VCP activity required for ERAD. Mol Cell 2006, 22:451-462.
• [17]Griciuc A, Aron L, Piccoli G, Ueffing M: Clearance of Rhodopsin(P23H) aggregates requires the ERAD effector VCP. Biochim Biophys Acta 1803, 2010:424-434.
• [18]Sharma RK, Johnson DA: Molecular signals for development of neuronal circuitry in the retina. Neurochem Res 2000, 25:1257-1263.
• [19]Strauss O: The retinal pigment epithelium in visual function. Physiol Rev 2005, 85:845-881.
• [20]Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, Sergeev Y, Chen W, Edwards AO, Stambolian D, Abecasis G, Swaroop A, Munson PJ, Miller SS: Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet 2010, 19:2468-2486.
• [21]Opefi CA, South K, Reynolds CA, Smith SO, Reeves PJ: Retinitis pigmentosa mutants provide insight into the role of the N-terminal cap in rhodopsin folding, structure, and function. J Biol Chem 2013, 288:33912-33926.
• [22]Yamasaki A, Hara T, Maejima I, Sato M, Sato K, Sato K: Rer1p regulates the ER retention of immature rhodopsin and modulates its intracellular trafficking. Sci Rep 2014, 4:5973.
• [23]Zhao Y, Hong DH, Pawlyk B, Yue G, Adamian M, Grynberg M, Godzik A, Li T: The retinitis pigmentosa GTPase regulator (RPGR)- interacting protein: subserving RPGR function and participating in disk morphogenesis. Proc Natl Acad Sci U S A 2003, 100:3965-3970.
• [24]Krebs MP, Holden DC, Joshi P, Clark CL 3rd, Lee AH, Kaushal S: Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J Mol Biol 2010, 395:1063-1078.
• [25]Kroeger H, Chiang WC, Lin JH: Endoplasmic reticulum-associated degradation (ERAD) of misfolded glycoproteins and mutant P23H rhodopsin in photoreceptor cells. Adv Exp Med Biol 2012, 723:559-565.
• [26]Griciuc A, Aron L, Roux MJ, Klein R, Giangrande A, Ueffing M: Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet 2010., 6(8) doi:10.1371/journal.pgen.1001075
• [27]Kang MJ, Ryoo HD: Suppression of retinal degeneration in Drosophila by stimulation of ER-associated degradation. Proc Natl Acad Sci U S A 2009, 106:17043-17048.
• [28]Shinde VM, Sizova OS, Lin JH, LaVail MM, Gorbatyuk MS: ER stress in retinal degeneration in S334ter Rho rats. PLoS One 2012, 7:e33266.
• [29]Chiang WC, Hiramatsu N, Messah C, Kroeger H, Lin JH: Selective activation of ATF6 and PERK endoplasmic reticulum stress signaling pathways prevent mutant rhodopsin accumulation. Invest Ophthalmol Vis Sci 2012, 53:7159-7166.
• [30]Kang MJ, Chung J, Ryoo HD: CDK5 and MEKK1 mediate pro-apoptotic signalling following endoplasmic reticulum stress in an autosomal dominant retinitis pigmentosa model. Nat Cell Biol 2012, 14:409-415.
• [31]Chiang WC, Messah C, Lin JH: IRE1 directs proteasomal and lysosomal degradation of misfolded rhodopsin. Mol Biol Cell 2012, 23:758-770.
• [32]Choudhury S, Bhootada Y, Gorbatyuk O, Gorbatyuk M: Caspase-7 ablation modulates UPR, reprograms TRAF2-JNK apoptosis and protects T17M rhodopsin mice from severe retinal degeneration. Cell Death Dis 2013, 4:e528.
• [33]Minamino T, Komuro I, Kitakaze M: Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res 2010, 107:1071-1082.
• [34]Brusilow SW, Maestri NE: Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996, 43:127-170.
• [35]Kubota K, Niinuma Y, Kaneko M, Okuma Y, Sugai M, Omura T, Uesugi M, Uehara T, Hosoi T, Nomura Y: Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. J Neurochem 2006, 97:1259-1268.
• [36]Mimori S, Okuma Y, Kaneko M, Kawada K, Hosoi T, Ozawa K, Nomura Y, Hamana H: Protective effects of 4-phenylbutyrate derivatives on the neuronal cell death and endoplasmic reticulum stress. Biol Pharm Bull 2012, 35:84-90.